This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mori, K. Articles by Maeda, M. Search for Related Content PubMed PubMed Citation Articles by Mori, K. Articles by Maeda, M.

(Stroke. 1995;26:1620-1626.)
© 1995 American Heart Association, Inc.

Articles

Hemorheological and Hemodynamic Analysis of Hypervolemic Hemodilution Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Kentaro Mori, MD; Hajime Arai, MD; Keiji Nakajima, MD; Atsushi Tajima, MD Minoru Maeda, MD

From the Department of Neurosurgery, Juntendo University Izunagaoka Hospital, Shizuoka, Japan.

Correspondence to Kentaro Mori, Department of Neurosurgery, Juntendo University Izunagaoka Hospital, 1129 Nagaoka Izunagaoka-cho, Tagata-gun, Shizuoka 410-22, Japan.

Background and Purpose Hypervolemic hemodilution therapy is effective for treating neurological deficits due to cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH). We monitored various hemorheological and hemodynamic parameters to assess the effects of hypervolemic hemodilution therapy in SAH patients with cerebral vasospasm.

Methods Ninety-eight patients who underwent early craniotomy for aneurysm clipping surgery after SAH were studied. Fifty-one patients (52.0%) developed symptomatic vasospasm. The hematocrit level and red blood cell aggregability were measured daily from day 1 to day 14, whereas the circulating blood volume and cerebral blood flow were measured periodically. Cardiac output and pulmonary capillary wedge pressure were also measured using a Swan-Ganz catheter.

Results The hematocrit level was decreased significantly to 29% to 32% by hypervolemic hemodilution therapy. Red blood cell aggregability increased until day 6 but was significantly reduced by therapy. Hypovolemia tended to develop after SAH. However, patients receiving hypervolemic hemodilution therapy became normovolemic to hypervolemic, with a significant increase of cardiac output and pulmonary capillary wedge pressure. At the onset of vasospasm, cerebral blood flow was significantly lower on the operated side than on the contralateral side, and it increased on both sides with therapy.

Conclusions Patients with SAH develop hypovolemia, hemodynamic depression, and increased red blood cell aggregability. Hypervolemic hemodilution therapy decreases hematocrit level and red cell aggregability while increasing cardiac output. Improvement of hemorheological and hemodynamic parameters by this therapy can reverse neurological deterioration due to cerebral vasospasm.

Key Words: erythrocyte aggregation • hemodilution • subarachnoid hemorrhage • vasospasm

This article has been cited by other articles:

				R. Hoff, G. Rinkel, B. Verweij, A. Algra, and C. Kalkman Blood Volume Measurement to Guide Fluid Therapy After Aneurysmal Subarachnoid Hemorrhage: A Prospective Controlled Study Stroke, July 1, 2009; 40(7): 2575 - 2577. [Abstract] [Full Text] [PDF]

				T. Mutoh, K. Kazumata, M. Ajiki, S. Ushikoshi, and S. Terasaka Goal-Directed Fluid Management by Bedside Transpulmonary Hemodynamic Monitoring After Subarachnoid Hemorrhage * Supplemental Material Stroke, December 1, 2007; 38(12): 3218 - 3224. [Abstract] [Full Text] [PDF]

				Y. Liu, V. Soppi, T. Mustonen, M. Kononen, T. Koivisto, A. Koskela, J. Rinne, and R. L. Vanninen Subarachnoid Hemorrhage in the Subacute Stage: Elevated Apparent Diffusion Coefficient in Normal-appearing Brain Tissue after Treatment Radiology, December 19, 2006; (2006) 2422051698. [Abstract] [Full Text]

				L. Belayev, Y. Liu, W. Zhao, R. Busto, and M. D. Ginsberg Human Albumin Therapy of Acute Ischemic Stroke : Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window Stroke, February 1, 2001; 32(2): 553 - 560. [Abstract] [Full Text] [PDF]

				L. Lennihan, S. A. Mayer, M. E. Fink, A. Beckford, M. C. Paik, H. Zhang, Y.-C. Wu, L. M. Klebanoff, E. C. Raps, and R. A. Solomon Effect of Hypervolemic Therapy on Cerebral Blood Flow After Subarachnoid Hemorrhage : A Randomized Controlled Trial Stroke, February 1, 2000; 31(2): 383 - 391. [Abstract] [Full Text] [PDF]

				S. A. Mayer, J. Lin, S. Homma, R. A. Solomon, L. Lennihan, D. Sherman, M. E. Fink, A. Beckford, and L. M. Klebanoff Myocardial Injury and Left Ventricular Performance After Subarachnoid Hemorrhage Stroke, April 1, 1999; 30(4): 780 - 786. [Abstract] [Full Text] [PDF]